Literature DB >> 3035476

Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985.

M F Rogers, P A Thomas, E T Starcher, M C Noa, T J Bush, H W Jaffe.   

Abstract

Since national surveillance for acquired immunodeficiency syndrome (AIDS) began in 1981, the Centers for Disease Control (CDC) has received reports of more than 20,000 cases of AIDS in the United States. As of December 31, 1985, 307 of these cases had been diagnosed in children younger than 13 years of age. The number of cases is increasing rapidly. The number of cases reported in 1985 more than doubled those reported in 1984. The major risk factors in children for acquiring infection with the causative agent, human immunodeficiency virus (HIV), were having a mother known to be infected and/or at increased risk for infection and receiving a transfusion of blood or blood products. Of the 307 children with AIDS, 73% were reported from one of four states: New York, New Jersey, Florida, and California. Most AIDS cases in children occur in black or Hispanic infants and toddlers. The estimated incubation period for AIDS in children has increased each surveillance year, with the longest incubation exceeding 7 years. The prognosis for children with AIDS is poor and infants less than 1 year of age have the shortest survival time following diagnosis. Continued national surveillance for AIDS is mandatory for establishing effective prevention programs to control the spread of the disease. The CDC encourages all health care personnel to report cases of AIDS to their public health departments.

Entities:  

Mesh:

Year:  1987        PMID: 3035476

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection.

Authors:  Cathryn Kurkjian; Melissa Hollifield; J Louise Lines; Amy Rogosky; Kerry M Empey; Mahboob Qureshi; Stephen A Brown; Beth A Garvy
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers.

Authors:  Sharon Shalekoff; Glenda E Gray; Caroline T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1.

Authors:  W Z Ho; J Lioy; L Song; J R Cutilli; R A Polin; S D Douglas
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults.

Authors:  B A Garvy; A G Harmsen
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  AIDS in schools and day-care centers.

Authors:  H Taras
Journal:  West J Med       Date:  1988-10

6.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?

Authors:  M M Chan; J M Campos; S Josephs; N Rifai
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 7.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 8.  Diagnosis and management of opportunistic infections in childhood AIDS.

Authors:  S Lal; D Sengupta
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

9.  Combined therapy in human immunodeficiency virus-infected children--a 4-year experience.

Authors:  T Güngör; M Funk; R Linde; I Kynast; A Allendorf; C Lotz; S Ehrenforth; D Hofmann; B Kornhuber; W Kreuz
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

10.  Subclinical Plasmodium falciparum infection and HIV-1 viral load.

Authors:  Kimberly C Brouwer; Lisa B Mirel; Chunfu Yang; Renu B Lal; Margarette S Kolczak; Anne M Van Eijk; John Ayisi; Juliana A Otieno; Bernard L Nahlen; Richard Steketee; Ya Ping Shi; Altaf A Lal
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.